{{Rsnum
|rsid=548726
|Chromosome=1
|position=5853561
|Orientation=plus
|GMAF=0.2098
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 53.1 | 39.8 | 7.1
| HCB | 81.0 | 18.2 | 0.7
| JPT | 76.1 | 22.1 | 1.8
| YRI | 63.0 | 30.8 | 6.2
| ASW | 56.1 | 43.9 | 0.0
| CHB | 81.0 | 18.2 | 0.7
| CHD | 80.7 | 19.3 | 0.0
| GIH | 49.5 | 40.6 | 9.9
| LWK | 70.4 | 27.8 | 1.9
| MEX | 60.3 | 29.3 | 10.3
| MKK | 71.0 | 27.7 | 1.3
| TSI | 44.1 | 47.1 | 8.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=5E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}